PDE5A and cancer: As the PDE5 enzyme is also distributed in many cells throughout the body, PDE5 inhibitors have the potential for wider use in different clinical conditions such as neurodegenerative disorders and brain injuries [4, 5], heart failure [6], and cancer [7].